Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-02-01

FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for buprenorphine from Actavis Pharma, Inc. under an approved ANDA, reflecting an added or updated aspect of the gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)